These press releases are intended for business journalists and analysts/investors
WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria
Zovirax Ophthalmic Ointment (aciclovir 3%) is impacted by an ongoing global supply constraint with no confirmed resupply date in Australia.
Read more - Update on supply of Zovirax Ophthalmic Ointment (aciclovir 3%) Read more
Australian campaign focuses on enlarged prostates
GSK Australia and New Zealand have published the third annual responsible business report, outlining key achievements in health, community and environmental sustainability.
Read more - GSK Australia releases 2014 Responsible Business Report Read more
GSK Australia has a new immunisation resource for Aboriginal and Torres Strait Islanders this month to encourage families to be proactive when it comes to immunising themselves and their children against preventable diseases.
GSK Australia is a recipient of a grant through of the Federal Government’s Manufacturing Transition Programme worth AUD$1 million. Funding will support GSK’s advanced manufacturing expansion plans at its Boronia site which focus on new product development using innovative “Blow-Fill-Seal” (BFS) technology.
GlaxoSmithKline (GSK) Australia reported to the Australian Securities and Investment Commission (ASIC) sales revenue of $906m in 2014 for its continuing operations and a profit before tax of $22m.
Read more - GSK Australia Reports 2014 results to ASIC Read more
Nominations for GSK’s Award for Research Excellence (ARE) open today for the 35th year running. The longstanding award acknowledges outstanding Australian researchers and their work and is accompanied by an $80K grant to assist the winner on their research journey.
Read more - GSK Award for Research Excellence opens Read more
GSK advises supply of new quadrivalent (four-strain) influenza vaccine, Fluarix® Tetra, recently launched in Australia and available for private sale, is no longer available for the remainder of the 2015 influenza season due to high levels of demand.
Read more - Supply update: Fluarix Tetra and Fluarix Read more
In 2014, GSK Australia made payments totalling $3,466,951 to healthcare professionals (HCPs) and health-related organisations (HCOs) for grants, sponsorships and consultancy fees related to chairing and speaking at meetings, assistance with training and participation in advisory boards.
Read more - GSK discloses payments to Australian healthcare professionals in 2014 Read more